Gardasil

Merck (MRK): Revenue Up 5%, But $550M Of Purchase Timing Was About Two-Thirds Of The Increase

Merck's Q3 revenue rose 5%, but about $550M of U.S. purchase timing made up roughly two-thirds of the increase, and Keytruda is 47% of sales.

Nov 1, 2026 · 7 min read